Profile data is unavailable for this security.
About the company
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
- Revenue in USD (TTM)358.76m
- Net income in USD3.00m
- Incorporated2018
- Employees584.00
- LocationTransmedics Group Inc200 Minuteman RoadANDOVER 01810United StatesUSA
- Phone+1 (978) 552-0900
- Websitehttps://www.transmedics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | 408.81m | -1.71m | 3.54bn | 797.00 | -- | 5.49 | 326.17 | 8.66 | -0.0291 | -0.0291 | 8.11 | 12.61 | 0.5856 | 1.12 | 7.81 | 512,934.80 | -0.2451 | -12.67 | -0.2618 | -13.76 | 75.89 | 70.04 | -0.4185 | -29.68 | 7.11 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Evolent Health Inc | 2.35bn | -106.20m | 3.58bn | 4.70k | -- | 3.35 | 234.05 | 1.52 | -0.9367 | -0.9367 | 20.71 | 10.79 | 0.9191 | -- | 6.55 | 500,823.00 | -2.91 | -9.60 | -3.63 | -12.59 | 18.57 | 24.50 | -3.16 | -13.66 | -- | -0.2382 | 0.326 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
| Neogen Corp | 924.22m | -9.42m | 3.80bn | 2.92k | -- | 1.21 | 35.40 | 4.11 | -0.0435 | -0.0435 | 4.27 | 14.51 | 0.203 | 2.85 | 5.67 | 316,839.90 | -0.207 | 1.38 | -0.214 | 1.44 | 50.19 | 48.23 | -1.02 | 4.31 | 2.59 | 1.19 | 0.2208 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Haemonetics Corporation | 1.33bn | 114.89m | 3.84bn | 3.66k | 33.63 | 4.24 | 17.61 | 2.88 | 2.23 | 2.23 | 25.92 | 17.70 | 0.5924 | 1.87 | 7.05 | 364,751.20 | 5.10 | 5.02 | 5.74 | 6.07 | 53.58 | 51.74 | 8.61 | 8.11 | 2.33 | 60.20 | 0.5747 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Procept Biorobotics Corp | 176.58m | -103.71m | 4.26bn | 626.00 | -- | 17.07 | -- | 24.11 | -2.06 | -2.06 | 3.50 | 4.85 | 0.546 | 1.85 | 3.83 | 282,068.70 | -32.07 | -- | -36.52 | -- | 54.73 | -- | -58.73 | -- | 6.49 | -- | 0.1696 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Integer Holdings Corp | 1.67bn | 105.37m | 4.41bn | 10.50k | 43.14 | 2.84 | 21.09 | 2.64 | 3.05 | 3.05 | 48.27 | 46.34 | 0.5574 | 4.88 | 5.10 | 158,938.20 | 3.52 | 3.28 | 3.78 | 3.53 | 26.77 | 26.94 | 6.31 | 6.40 | 1.96 | 3.67 | 0.4215 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| ICU Medical Inc | 2.30bn | -70.79m | 4.43bn | 14.00k | -- | 2.17 | 28.23 | 1.92 | -2.92 | -2.92 | 94.90 | 83.43 | 0.5267 | 2.13 | 14.68 | 164,591.20 | -1.62 | 1.46 | -1.83 | 1.65 | 32.47 | 34.11 | -3.07 | 2.23 | 1.08 | 0.5555 | 0.4412 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -185.00m | 5.45bn | 15.00k | -- | 1.78 | 33.25 | 1.40 | -0.8698 | -0.8698 | 18.65 | 15.12 | 0.5356 | 2.94 | 6.18 | 259,733.30 | -2.49 | -1.14 | -3.03 | -1.32 | 52.23 | 53.65 | -4.65 | -2.51 | 0.8692 | 3.65 | 0.4066 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| TransMedics Group Inc | 358.76m | 3.00m | 5.54bn | 584.00 | 4,022.78 | 29.12 | 318.25 | 15.43 | 0.0413 | 0.0413 | 10.61 | 5.70 | 0.4952 | 3.56 | 5.58 | 614,313.40 | 0.4141 | -16.08 | 0.4403 | -17.95 | 60.71 | 65.37 | 0.8362 | -40.47 | 8.48 | -- | 0.7278 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Merit Medical Systems Inc | 1.30bn | 117.43m | 5.83bn | 6.95k | 49.96 | 4.55 | 27.42 | 4.48 | 2.01 | 2.01 | 22.24 | 22.04 | 0.6183 | 2.30 | 7.36 | 187,231.10 | 5.58 | 2.45 | 6.13 | 2.77 | 46.54 | 44.50 | 9.02 | 3.91 | 4.64 | 17.52 | 0.3846 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Masimo Corp | 2.02bn | 79.40m | 5.97bn | 3.80k | 76.00 | 4.34 | 34.22 | 2.96 | 1.47 | 1.47 | 37.32 | 25.73 | 0.6831 | 1.94 | 5.77 | 530,763.20 | 2.69 | 8.65 | 3.32 | 10.31 | 49.28 | 57.30 | 3.94 | 12.03 | 1.15 | 3.30 | 0.3635 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Stevanato Group SpA | 1.21bn | 136.79m | 6.01bn | 5.64k | 38.67 | 3.67 | 26.53 | 4.95 | 0.5135 | 0.5135 | 4.54 | 5.42 | 0.543 | 2.66 | 2.80 | 215,421.50 | 6.12 | -- | 8.34 | -- | 30.06 | -- | 11.27 | -- | 1.13 | 44.77 | 0.1926 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Inspire Medical Systems Inc | 705.71m | 6.01m | 6.33bn | 1.01k | 1,096.01 | 9.91 | 642.54 | 8.96 | 0.1935 | 0.1935 | 23.74 | 21.41 | 1.05 | 2.68 | 9.86 | 698,026.70 | 0.8927 | -11.27 | 0.99 | -12.60 | 84.83 | 84.47 | 0.8518 | -13.57 | 8.35 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Glaukos Corp | 341.73m | -158.61m | 7.15bn | 907.00 | -- | 10.72 | -- | 20.92 | -3.20 | -3.20 | 6.91 | 12.13 | 0.3642 | 1.67 | 7.55 | 376,764.10 | -16.91 | -8.73 | -18.20 | -9.35 | 76.53 | 74.77 | -46.41 | -28.69 | 4.67 | -56.93 | 0.16 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Lantheus Holdings Inc | 1.44bn | 428.48m | 7.54bn | 834.00 | 17.78 | 7.34 | 15.43 | 5.24 | 6.11 | 6.11 | 20.48 | 14.79 | 0.8775 | 8.35 | 4.58 | 1,724,234.00 | 26.15 | 6.69 | 29.96 | 7.73 | 64.49 | 57.56 | 29.80 | 9.02 | 4.41 | -- | 0.3546 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Data as of Sep 20 2024. Currency figures normalised to Transmedics Group Inc's reporting currency: US Dollar USD
49.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 4.07m | 12.20% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 2.43m | 7.28% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 2.34m | 7.03% |
| Driehaus Capital Management LLCas of 30 Jun 2024 | 1.49m | 4.46% |
| Invesco Advisers, Inc.as of 30 Jun 2024 | 1.27m | 3.81% |
| Eventide Asset Management LLCas of 30 Jun 2024 | 1.15m | 3.43% |
| ArrowMark Colorado Holdings LLCas of 30 Jun 2024 | 1.14m | 3.41% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 956.30k | 2.87% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 782.79k | 2.35% |
| Geode Capital Management LLCas of 30 Jun 2024 | 753.68k | 2.26% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
